OrthoPediatrics Corp. (KIDS)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, OrthoPediatrics Corp. currently loses $10.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 27
in 2 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Next report — what to expect
OrthoPediatrics Corp. (KIDS) reports next on October 27, 2026. Wall Street is looking for EPS of -$0.25 on revenue of $68.5 million. For trailing context, revenue grew 15.4% year over year last quarter. The company has beaten EPS in 4 of its 8 most recent quarters.
About OrthoPediatrics Corp.
OrthoPediatrics Corp. develops and sells pediatric orthopedic medical devices, trading on the NASDAQ as KIDS, with $236.3 million in revenue for FY2025. The company focuses on specialized implants and devices designed for children with orthopedic conditions, spanning trauma, deformity correction, spine, and sports medicine applications.
Today's Snapshot
The day ended with KIDS 0.8% lower at 24.50, in line with a weaker sector. Shares changed hands at about two-thirds of its usual level. KIDS reports earnings on 27 October.
Trading Volume
Below 10d avg (251.2K)
149K
vs S&P 500 Today
Moderate Underperformance
-0.33%
Updated: October 23, 2026 at 20:07 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$19.97 - $23.30Buy
- RSI (14)64.55Neutral
- Stochastic %K (14, 3, 3)92.99Sell
- MACD Level (12, 26)0.36Buy
Get premium market insights delivered directly to your inbox.